In the BioHarmony Drug Report Database
Mirapex, Mirapex Er, Mirapexin, Sifrol (pramipexole) is a small molecule pharmaceutical. Pramipexole was first approved as Mirapex on 1997-07-01. It is used to treat depressive disorder and parkinson disease in the USA. It has been approved in Europe to treat parkinson disease and restless legs syndrome. The pharmaceutical is active against D(2) dopamine receptor and D(3) dopamine receptor. Mirapex’s patents are valid until 2029-09-08 (FDA).
Image (chem structure or protein)